Resurgence of Polymyxin B for MDR/XDR Gram-Negative Infections: An Overview of Current Evidence-Reference-Cited by-同舟云学术

Resurgence of Polymyxin B for MDR/XDR Gram-Negative Infections: An Overview of Current Evidence

Published:2017 Issue: Volume:2017 Page:1-10
ISSN:2090-1305
Container-title:Critical Care Research and Practice
language:en
Short-container-title:Critical Care Research and Practice

Author:

Garg Suneel Kumar¹,Singh Omender¹,Juneja Deven¹,Tyagi Niraj²,Khurana Amandeep Singh³,Qamra Amit³,Motlekar Salman³^ORCID,Barkate Hanmant³

Affiliation:

1. Institute of Critical Care Medicine, Max Super Specialty Hospital, Saket, New Delhi 110017, India

2. Department of Critical Care and Emergency Medicine, Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi 110060, India

3. Department of Medical Affairs, Wockhardt Ltd., Wockhardt Towers, Mumbai 400051, India

Abstract

Polymyxin B has resurged in recent years as a last resort therapy for Gram-negative multidrug-resistant (MDR) and extremely drug resistant (XDR) infections. Understanding newer evidence on polymyxin B is necessary to guide clinical decision making. Here, we present a literature review of polymyxin B in Gram-negative infections with update on its pharmacology.

Publisher

Hindawi Limited

Subject

Critical Care and Intensive Care Medicine

Link

http://downloads.hindawi.com/journals/ccrp/2017/3635609.pdf

Reference62 articles.

1. Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment

2. Reviving old antibiotics

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymyxin B adjuvants against polymyxin B- and carbapenem-resistant Gram-negative bacteria;Future Microbiology;2024-09-11

2. Comparison of the Impact of VRP-034 and Polymyxin B upon Markers of Kidney Injury in Human Proximal Tubule Monolayers In Vitro;Antibiotics;2024-06-06

3. The role of aztreonam in rational antibacterial therapy of resistant nosocomial gram-negative infections. The new life for a well-known β-lactam;EMERGENCY MEDICINE;2024-05-17

4. β-lactam-induced OMV release promotes polymyxin tolerance in Salmonella enterica sv. Typhi;Frontiers in Microbiology;2024-03-25

5. Enhancing colistin efficacy against Salmonella infections with a quinazoline-based dual therapeutic strategy;Scientific Reports;2024-03-01